Literature DB >> 24186911

Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program.

Yogesh Moradiya1, Howard Crystal, Helen Valsamis, Steven R Levine.   

Abstract

OBJECTIVE: We aimed to compare the rates of thrombolysis utilization for acute ischemic stroke in hospitals with neurology residency (NR) to those of other teaching (OT) and nonteaching (NT) hospitals.
METHODS: A retrospective serial cross-sectional cohort study of a nationally representative sample of stroke patients was conducted. Accreditation Council for Graduate Medical Education-accredited NR program-affiliated hospitals in the United States were cross-matched to the hospitals in the Nationwide Inpatient Sample from 2000 to 2010. ICD-9-CM codes were used for case ascertainment.
RESULTS: A total of 712,433 adult ischemic stroke patients from 6,839 hospital samples were included, of whom 10.1%, 29.1%, and 60.8% were treated in NR, OT, and NT hospitals, respectively. Stroke patients in NR received thrombolysis more frequently (3.74% ± 0.24% [standard error]) than in OT (2.28% ± 0.11%, p < 0.001) and NT hospitals (1.44% ± 0.06%, p < 0.001). The adjusted odds ratios (ORs) of thrombolysis rates in NR vs OT and NR vs NT increased with each decade increment in age. In multivariate analysis, NR was independently predictive of higher thrombolysis rate (adjusted OR 1.51; 95% confidence interval [CI] 1.44-1.59 [NR vs OT], and adjusted OR 1.82; 95% CI 1.73-1.91 [NR vs NT]).
CONCLUSIONS: Acute stroke care in NR hospitals is associated with an increased thrombolytic utilization. The disparities between the thrombolysis rate in NR and that in OT and NT hospitals are greater among elderly patients.

Entities:  

Mesh:

Year:  2013        PMID: 24186911      PMCID: PMC3854832          DOI: 10.1212/01.wnl.0000436946.08647.b5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Authors:  Opeolu Adeoye; Richard Hornung; Pooja Khatri; Dawn Kleindorfer
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

2.  Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Authors:  Natalia S Rost; Eric E Smith; Muhammad A Pervez; Philip Mello; Paul Dreyer; Lee H Schwamm
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-24

Review 3.  A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data.

Authors:  Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Jane S Saczynski; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

4.  The use and misuse of thrombolytic therapy within the Veterans Health Administration.

Authors:  Salomeh Keyhani; Greg Arling; Linda S Williams; Joseph S Ross; Diana L Ordin; Jennifer Myers; Gary Tyndall; Bruce Vogel; Dawn M Bravata
Journal:  Med Care       Date:  2012-01       Impact factor: 2.983

5.  Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke.

Authors:  Gregg C Fonarow; Mathew J Reeves; Xin Zhao; DaiWai M Olson; Eric E Smith; Jeffrey L Saver; Lee H Schwamm
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

6.  Intravenous thrombolysis for stroke increases over time at primary stroke centers.

Authors:  Shyam Prabhakaran; Maggie McNulty; Kathleen O'Neill; Bichun Ouyang
Journal:  Stroke       Date:  2011-12-01       Impact factor: 7.914

7.  Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke.

Authors:  Deena M Nasr; Waleed Brinjikji; Harry J Cloft; Alejandro A Rabinstein
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-11       Impact factor: 2.136

8.  National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.

Authors:  Dawn Kleindorfer; Christopher J Lindsell; Lawrence Brass; Walter Koroshetz; Joseph P Broderick
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

9.  Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010.

Authors:  Norrina B Allen; Lisa Kaltenbach; Larry B Goldstein; DaiWai M Olson; Eric E Smith; Eric D Peterson; Lee Schwamm; Judith H Lichtman
Journal:  Stroke       Date:  2012-05-15       Impact factor: 7.914

10.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

View more
  13 in total

1.  Patient Age and the Outcomes after Decompressive Hemicraniectomy for Stroke: A Nationwide Inpatient Sample Analysis.

Authors:  Hormuzdiyar H Dasenbrock; Faith C Robertson; M Ali Aziz-Sultan; Donovan Guittieres; Rose Du; Ian F Dunn; William B Gormley
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

2.  Interfacility transfers for US ischemic stroke and TIA, 2006-2014.

Authors:  Benjamin P George; Sara J Doyle; George P Albert; Ania Busza; Robert G Holloway; Kevin N Sheth; Adam G Kelly
Journal:  Neurology       Date:  2018-04-04       Impact factor: 9.910

3.  Stroke 20 20: Implementation goals for intravenous thrombolysis.

Authors:  Robert Mikulik; Michal Bar; David Cernik; Roman Herzig; Rene Jura; Lubomir Jurak; Jiri Neumann; Daniel Sanak; Svatopluk Ostry; Petr Sevcik; Ondrej Skoda; David Skoloudik; Daniel Vaclavik; Ales Tomek
Journal:  Eur Stroke J       Date:  2021-04-12

4.  Simple but Organized Neurology Residency Training Improves the Quality of Acute Stroke Care: From the Outset to Long-Term Effect.

Authors:  Yu-Ming Chang; Chun-Min Wang; Po-Yu Lin; Pi-Shan Sung; Sheng-Hsiang Lin; Chih-Hung Chen
Journal:  J Stroke       Date:  2021-05-31       Impact factor: 6.967

Review 5.  How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.

Authors:  Christine L Paul; Annika Ryan; Shiho Rose; John R Attia; Erin Kerr; Claudia Koller; Christopher R Levi
Journal:  Implement Sci       Date:  2016-04-08       Impact factor: 7.327

6.  Is cirrhosis associated with lower odds of ischemic stroke: A nationwide analysis?

Authors:  Abhinav Goyal; Kshitij Chatterjee; Nishi Shah; Shailender Singh
Journal:  World J Hepatol       Date:  2016-12-18

7.  The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT.

Authors:  T P Zonneveld; A Algra; D W J Dippel; L J Kappelle; R J van Oostenbrugge; Y B W E M Roos; M J Wermer; H B van der Worp; P J Nederkoorn; N D Kruyt
Journal:  BMC Neurol       Date:  2015-11-23       Impact factor: 2.474

8.  Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.

Authors:  Mai N Nguyen-Huynh; Jeffrey G Klingman; Andrew L Avins; Vivek A Rao; Abigail Eaton; Sunil Bhopale; Anne C Kim; John W Morehouse; Alexander C Flint
Journal:  Stroke       Date:  2017-12-15       Impact factor: 7.914

9.  Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes.

Authors:  Marco Gonzalez-Castellon; Christine Ju; Ying Xian; Adrian Hernandez; Gregg C Fonarow; Lee Schwamm; Eric E Smith; Deepak L Bhatt; Matthew Reeves; Joshua Z Willey
Journal:  J Am Heart Assoc       Date:  2018-01-31       Impact factor: 5.501

10.  Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases.

Authors:  Kori S Zachrison; Sijia Li; Mathew J Reeves; Opeolu Adeoye; Carlos A Camargo; Lee H Schwamm; Renee Y Hsia
Journal:  Stroke Vasc Neurol       Date:  2020-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.